Companies / Health Care / Biotechnology
Gilead Sciences stock buybacks
GILD$1.4Bbought back in the 12 months to Jun 30, 2026
Gilead Sciences bought back $1.4B of its stock in the last twelve months, $530M more than it paid out in stock compensation. Its share count is down 1.0% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $201M |
| Q4 '20 | $0 |
| Q1 '21 | $309M |
| Q2 '21 | $43M |
| Q3 '21 | $145M |
| Q4 '21 | $49M |
| Q1 '22 | $352M |
| Q2 '22 | $72M |
| Q3 '22 | $180M |
| Q4 '22 | $792M |
| Q1 '23 | $400M |
| Q2 '23 | $150M |
| Q3 '23 | $300M |
| Q4 '23 | $150M |
| Q1 '24 | $400M |
| Q2 '24 | $100M |
| Q3 '24 | $300M |
| Q4 '24 | $350M |
| Q1 '25 | $730M |
| Q2 '25 | $527M |
| Q3 '25 | $435M |
| Q4 '25 | $230M |
| Q1 '26 | $419M |
| Q2 '26 | $355M |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 1.26B |
| Q4 '20 | 1.27B |
| Q1 '21 | 1.26B |
| Q2 '21 | 1.26B |
| Q3 '21 | 1.26B |
| Q4 '21 | 1.26B |
| Q1 '22 | 1.26B |
| Q2 '22 | 1.26B |
| Q3 '22 | 1.26B |
| Q4 '22 | 1.26B |
| Q1 '23 | 1.26B |
| Q2 '23 | 1.26B |
| Q3 '23 | 1.26B |
| Q4 '23 | 1.26B |
| Q1 '24 | 1.25B |
| Q2 '24 | 1.25B |
| Q3 '24 | 1.25B |
| Q4 '24 | 1.27B |
| Q1 '25 | 1.26B |
| Q2 '25 | 1.25B |
| Q3 '25 | 1.25B |
| Q4 '25 | 1.25B |
| Q1 '26 | 1.25B |
| Q2 '26 | 1.24B |
$355Mlast quarter (Q2 2026)
$530Mnet of stock compensation ($909M)
−1.0%diluted shares, 1 year
−0.6%diluted shares, 5 years
$4.1Bdividends, 12 months
11%of free cash flow ($12.9B) spent on buybacks
$304Mraised by issuing stock, 12 months
1.24Bshares outstanding (Jul 31, 2026)
Share counts are adjusted for a stock split (2-for-1).
By fiscal year
Questions
- Does Gilead Sciences buy back its stock?
- Gilead Sciences bought back $1.4B of its stock in the last twelve months, $530M more than it paid out in stock compensation. Its share count is down 1.0% from a year earlier.
- How much did Gilead Sciences spend on buybacks in fiscal 2025?
- $1.9B, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Gilead Sciences's share count going down?
- Its diluted share count changed −0.6% over five fiscal years and −1.0% over the last year.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 6, 2026 · open on SEC.gov